DNASE1L3-expressing dendritic cells promote CD8+ T cell function and anti-PD-(L)1 therapy efficacy by degrading neutrophil extracellular traps
Degao Chen(Army Medical University), Quanxing Liu(Army Medical University), Haoran Zha(Army Medical University), Yisong Y. Wan(University of North Carolina at Chapel Hill), Jigang Dai(Ministry of Education of the People's Republic of China), Haixia Long(Army Medical University), Qingzhu Jia(Army Medical University), Ting Yuan(Goethe University Frankfurt), Yangping Bian(Army Medical University), Qi-Jing Li(Agency for Science, Technology and Research), Yucui Wu(Army Medical University), Xindong Liu(Army Medical University), Qian Chu(Ludong University), Li Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Lei Wang(China Pharmaceutical University), Wenfeng Fang(Sun Yat-sen University), Chu Han, Dong Zhou(Harbin Veterinary Research Institute), Hao Lv(Army Medical University), Qiuyu Xia(Chongqing University), Xiaoming Cheng(Army Medical University)
Cited by 28
Related Papers
Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
|Signal Transduction and Targeted Therapy|2021|1.7k
Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression
|Nature|2007|856
New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis
|Redox Biology|2018|753
Clinical characteristics of 82 cases of death from COVID-19
|PLoS ONE|2020|594